These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2110966)

  • 1. Effect of cysteamine on the lysosomal enzymes of the hyperprolactinaemic rat pituitary.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Apr; 125(1):75-80. PubMed ID: 2110966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Oct; 127(1):119-27. PubMed ID: 2103572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy of cysteamine in depleting prolactin immunoreactivity in different hyperprolactinemic animal models.
    Millard WJ; Romano TM
    Life Sci; 1991; 49(22):1635-42. PubMed ID: 1943468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Mar; 124(3):397-402. PubMed ID: 2332716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bromocriptine on pituitary organelle marker enzyme activities in lactating and postlactating rats: selective activation of lysosomal prolactin proteolytic activity.
    De Marco L; Mashiter K; Caughey B; Peters TJ
    Endocrinology; 1984 Sep; 115(3):984-9. PubMed ID: 6086293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal enzymes in the rat harderian gland are altered by either bromocriptine treatment or hypophysectomy and hormone replacement therapy.
    Vaughan MK; Chenoweth PC; Sabry I; Chambers JP; Reiter RJ
    Proc Soc Exp Biol Med; 1988 Apr; 187(4):469-73. PubMed ID: 2965392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine depletes prolactin in young and old hyperprolactinemic rats.
    Simpkins JW; Estes KS; Millard WJ; Sagar SM; Martin JB
    Endocrinology; 1983 May; 112(5):1889-91. PubMed ID: 6832077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a direct correlation between the activities of various lysosomal enzymes and prolactin secretion in the rat anterior pituitary?
    Nagy I; Rappay G; Makara GB; Horvath G; Bacsy E; MacLeod RM
    Endocrinology; 1983 Feb; 112(2):470-5. PubMed ID: 6848358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
    Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
    Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
    Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
    Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cysteamine on suckling-induced prolactin secretion in the rat.
    Millard WJ; O'Sullivan D; Riskind PN
    Life Sci; 1987 Nov; 41(20):2255-60. PubMed ID: 3683075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological manipulation of anterior pituitary dopamine content in the male rat: relationship to serum prolactin concentration and lysosomal enzyme activity.
    Demarest KT; Riegle GD; Moore KE
    Endocrinology; 1984 Aug; 115(2):493-500. PubMed ID: 6745164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
    Scammell JG; Dannies PS
    Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the low beta-galactosidase activity in cystinotic fibroblasts: effects of cysteamine.
    Kooistra T; Lloyd JB
    Clin Chim Acta; 1985 Jan; 145(1):9-16. PubMed ID: 3919971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
    Scott JS; Lakin CA; Oliver JR
    Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lysosomal activity in prolactin cells under the effect of a dopamine agonist].
    Bácsy E; Vu Duc Moi ; Rappay G; Gaál G
    Acta Histochem Suppl; 1986; 33():221-4. PubMed ID: 3090629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
    Ward WF; Moss AL
    Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen alters the responsiveness of the anterior pituitary gland to the actions of dopamine on lysosomal enzyme activity and prolactin release.
    Nansel DD; Gudelsky GA; Reymond MJ; Porter JC
    Endocrinology; 1981 Mar; 108(3):903-7. PubMed ID: 7460850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine: a potent and specific depletor of pituitary prolactin.
    Millard WJ; Sagar SM; Landis DM; Martin JB
    Science; 1982 Jul; 217(4558):452-4. PubMed ID: 7089575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic perturbation of rat liver lysosomes: effects on release of lysosomal enzymes and of lipids into bile.
    Sewell RB; Grinpukel SA; Zinsmeister AR; LaRusso NF
    Gastroenterology; 1988 Oct; 95(4):1088-98. PubMed ID: 3137115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.